共 290 条
[1]
Chanchlani R(2016)Ethnic differences in childhood nephrotic syndrome Front Pediatr 4 39-434
[2]
Parekh RS(2020)Prediction of short- and long-term outcomes in childhood nephrotic syndrome Kidney Int Rep 5 426-776
[3]
Carter SA(1997)Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children J Am Soc Nephrol 8 769-919
[4]
Mistry S(2023)IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome Pediatr Nephrol 38 877-S276
[5]
Fitzpatrick J(2021)KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases Kidney Int 100 S1-1315
[6]
Banh T(2011)Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial Clin J Am Soc Nephrol 6 1308-1281
[7]
Hebert D(2014)Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial Lancet 384 1273-2212
[8]
Langlois V(2018)Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: a multicenter open-label trial in Korea Medicine 97 e13157-1207
[9]
Pearl RJ(2010)Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report Clin J Am Soc Nephrol 5 2207-619
[10]
Chanchlani R(2022)Long-term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: an international study J Am Soc Nephrol 33 1193-96